Johnson & Johnson (NYSE:JNJ) shares, rose in value, with the stock price down by -0.69% to the previous day’s close as strong demand from buyers drove the stock to $148.53.
Actively observing the price movement in the last trading, the stock closed the session at $149.56. The PE ratio was 19.03 over 12-month period. Referring to stock’s 52-week performance, its high was $175.97, and the low was $143.13. On the whole, JNJ has fluctuated by -4.31% over the past month.
The company’s Forward Dividend Ratio is 4.76, with its dividend yield at 3.20%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 88.38B, with a low estimate of 21.9B and a high estimate of 22.61B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 22.34B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that JNJ’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 3.64, with the price of JNJ currently trading nearly -1.83% and -4.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.59, while the 7-day volatility ratio is showing 1.87% which for the 30-day chart, stands at 1.49%. Furthermore, Johnson & Johnson (JNJ)’s beta value is 0.54, and its average true range (ATR) is 2.37.
A comparison of Johnson & Johnson (JNJ) with its peers suggests the former has fared considerably weaker in the market. JNJ showed an intraday change of -0.69% in last session, and over the past year, it shrunk by -9.26%%.
Data on historical trading for Johnson & Johnson (NYSE:JNJ) indicates that the trading volumes over the past 3 months, they’ve averaged 7.56 million. According to company’s latest data on outstanding shares, there are 2.41 billion shares outstanding.
Nearly 0.16% of Johnson & Johnson’s shares belong to company insiders and institutional investors own 71.38% of the company’s shares. The stock has fallen by -5.24% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the JNJ stock heading into the next quarter.
